C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CEACAM7 | Carcinoembryonic antigen-related cell adhesion molecule 7 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CLCA4 | Chloride channel accessory 4 | Predicted membrane proteins
| | | | | Group enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | | Group enriched |
INSL5 | Insulin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
MUC12 | Mucin 12, cell surface associated | Predicted membrane proteins
| | | | | Group enriched |
NOX1 | NADPH oxidase 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
NXPE1 | Neurexophilin and PC-esterase domain family, member 1 | Predicted membrane proteins
| | | | | Group enriched |
SATB2 | SATB homeobox 2 | Disease related genes Transcription factors
| | | | | Group enriched |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | | | | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CLCA1 | Chloride channel accessory 1 | Predicted secreted proteins
| | | | | Group enriched |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | | | | | | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GPA33 | Glycoprotein A33 (transmembrane) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | | | | Group enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | | | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC2 | Mucin 2, oligomeric mucus/gel-forming | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
PYY | Peptide YY | Predicted secreted proteins
| | | | | Group enriched |
REG4 | Regenerating islet-derived family, member 4 | Predicted secreted proteins
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted secreted proteins
| | | | | Group enriched |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes
| | | | | Group enriched |
SULT1B1 | Sulfotransferase family, cytosolic, 1B, member 1 | Plasma proteins
| | | | | Group enriched |
TPH1 | Tryptophan hydroxylase 1 | Enzymes FDA approved drug targets
| | | | | Group enriched |
TPSG1 | Tryptase gamma 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Group enriched |